Oncology

Cancer immunotherapy update

Review of immune checkpoint inhibitor and CAR T-cell therapy adverse effects and treatments. Takeaways: The U.S. Food and Drug Administration has approved several immunotherapy agents to treat cancer, including immune checkpoint inhibitors and chimeric antigen...

Let’s call her Carol

It was my first year as a nurse in a suburban Intensive Care unit. I worked the night shift and had an elderly female patient that was very ill with cancer, I don’t remember...

Scientists can silence inflammatory gene responsible for a form of breast cancer

Scientists have found that they are able to “switch off,” or silence, a gene that is responsible for an aggressive form of breast cancer. Researchers worked with two known breast cancer genes, Rab27a and TRAF31P2,...

My cancer journey

I’m a nurse. I’m not supposed to be a patient. I’m not supposed to get cancer. I have too much to do to add cancer and its treatment to my life. I don’t want...

New treatment for multiple myeloma

The U.S. Food and Drug Administration (FDA) recently approved Sanofi-Aventis’ Sarclisa (isatuximab-irfc) for the treatment of  adult patients with multiple myeloma. Isatuximab-irfc was previously designated its orphan drug status by the FDA. Isatuximab-irfc was approved...

Study examines rate of cancer overdiagnosis in Australia

A recent study published in the Medical Journal of Australia examined the “proportion of cancer diagnoses in Australia that might reasonably be attributed to overdiagnosis.” The research team collected data between 1982 and 2012 from...

New vaccine eliminated breast cancer in first human patient

A vaccine being developed in the Mayo Clinic in Jacksonville, Florida is aimed at preventing new cases of ovarian and breast cancer and even recurring cases of these cancers. The vaccine is currently being tested,...

The World Health Organization aims to reduce mortality of cervical cancer

In a recent study, the World Health Organization (WHO) describes a study which aims to eliminate cervical cancer “as a public health problem.” This goal is planned to be achieved through the WHO’s Cervical Cancer...

New treatment for advanced epithelioid sarcoma

The U.S. Food and Drug Administration (FDA) recently approved Epizyme, Inc’s tazemetostat (TAZVERIK) for the treatment of adult and pediatric patients with metastatic or advanced epithelioid sarcoma (AES). AES is a rare sarcoma that affects...

Take Care of Yourself

How many of you hear the phrase “self-care” and roll your eyes? I know. Because that’s my reaction, too. As if nurses’ endless task lists can accommodate one more thing: to take care of...

New findings from the American Cancer Society on reduced cancer mortality rates

Based on new findings from a 2020 American Cancer Society report, mortality rates from cancer have declined by 29% between 1991 to 2017 in the US. Additionally, between 2016 to 2017, there was a...

Oncology nursing core competencies

As more patients survive cancer, nursing education must meet the demand for nurses who can care for them. Takeaways At the same time that death rates from cancer continue to decline, the numbers of cancer...

Accelerated approval for new sickle cell disease treatment

The U.S. Food and Drug Administration (FDA) recently granted accelerated approval to Global Blood Therapeutics’ voxelotor (Oxbryta), a treatment for adults and pediatric patients (12 years and older) with sickle cell disease (SCD). SCD is...